Skip to Content

Paromomycin Pregnancy and Breastfeeding Warnings

Paromomycin is also known as: Humatin, Paromycin

Paromomycin Pregnancy Warnings

Paromomycin has not been formally assigned to a pregnancy category by the FDA. Paromomycin is poorly absorbed from the gastrointestinal tract; therefore, little drug would be available to reach the fetus. There are no data linking the use of paromomycin to congenital malformations or fetal toxicity, although there are no controlled data in human pregnancy. In pregnant patients with symptomatic protozoan or tapeworm infections, paromomycin may be a therapeutic option. Paromomycin should only be given during pregnancy when there are no alternatives and benefit outweighs the risk.

In one report, two women were treated with paromomycin for 10 days for symptomatic Giardia infections during the 10th and 20th week of pregnancy. No congenital malformations or fetal toxicity were reported.

See references

Paromomycin Breastfeeding Warnings

Paromomycin is poorly absorbed from the gastrointestinal tract; therefore, any excretion into breast milk is expected to be minimal.

See references

References for pregnancy information

  1. "Product Information. Humatin (paromomycin)." Parke-Davis, Morris Plains, NJ.
  2. Kreutner AK, Del Bene VE, Amstey MS "Giardiasis in pregnancy." Am J Obstet Gynecol 140 (1981): 895-901

References for breastfeeding information

  1. "Product Information. Humatin (paromomycin)." Parke-Davis, Morris Plains, NJ.

Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.